Catalyst
Slingshot members are tracking this event:
Janssen's (JNJ) Stelara Approved by European Commission for Adults with Moderately to Severely Active Crohn's Disease
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| JNJ |
|
|
Janssen Biotech |
|
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 11, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Stelara, European Commission, Moderate-to-severely Active, Crohn's Disease, Approval
